Ali R Keramati,Mohammadali Habibi
Ali R Keramati
Michael Lloyd,Jayanthi Koneru
Michael Lloyd
Antiarrhythmic Medications in Patients with Adult Congenital Heart Disease [0.03%]
成人先天性心脏病患者的抗心律失常药物治疗
Rawan Amir,Jenna A Milstein,Konstantinos N Aronis
Rawan Amir
Arrhythmias are a leading cause of morbidity, mortality, and impaired quality of life in the rapidly growing adult congenital heart disease (ACHD) population. Despite advances in catheter ablation, anti-arrhythmic drugs (AADs) continue to p...
Antiarrhythmic Medications for Acute Management of Ventricular Arrhythmias [0.03%]
急性室性心律失常的抗心律失常药物治疗
Jose Fernandez Sanchez,Sean Paul Gaine,Konstantinos N Aronis
Jose Fernandez Sanchez
Antiarrhythmic medications play a crucial role in the acute management of ventricular arrhythmias. Determining the most appropriate, effective, and safe antiarrhythmic medication to use in each clinical scenario requires careful considerati...
Advances in Antiarrhythmic Drug Therapy: Chronic Maintenance of Normal Sinus Rhythm Using Anti-arrhythmic Drugs in Patients with Atrial Fibrillation and Atrial Flutter [0.03%]
抗心律失常药物治疗进展——对房颤和房扑患者的窦性心律的长期维持治疗
Nikola Kocovic,Steven Liskov
Nikola Kocovic
Atrial fibrillation (AF) is the most common arrhythmia worldwide and represents a significant source of morbidity. Maintenance of sinus rhythm is associated with improvement in systolic heart failure, as well as lower risk of hospitalizatio...
Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter [0.03%]
房颤和房性心动过速的急性期抗心律失常药物治疗
Mohammadali Habibi,Muhammed Rahim,Suneet Mittal
Mohammadali Habibi
This review outlines the pharmacologic strategies for acute management of atrial fibrillation and atrial flutter, with a focus on rate and rhythm control. It details the efficacy, indications, and safety profiles of commonly used agents, in...
Advances in Antiarrhythmic Drug Therapy: Pharmacologic Management of Supraventricular Tachycardia [0.03%]
抗心律失常药治疗进展——房性心动过速的药物治疗学管理
Mohammed Kamareddine,Ali R Keramati
Mohammed Kamareddine
Pharmacologic management remains indispensable in supraventricular tachycardia despite ablation's curative potential. In stable patients, vagal maneuvers precede drugs; adenosine's ultrashort action makes it first-line, with intravenous cal...
Paul Y Lee,Juan Bello,Hirad Yarmohammadi
Paul Y Lee
Antiarrhythmics have been cornerstones in the treatment of various arrhythmia. As with all medications, they pose side effects that should be weighed into the decision of administering the medication. These 4 classes of antiarrhythmics have...
John Lindsley,Kristen Bova Campbell
John Lindsley
The pharmacokinetic and pharmacodynamic characteristics of antiarrhythmic drugs (AADs) help guide agent selection, dosing, and monitoring. Many AADs have complex mechanisms and require close monitoring to prevent adverse effects. The pharma...
Farah Olleik,Peter R Kowey
Farah Olleik
Antiarrhythmic drug therapy continues to be the cornerstone of management of both atrial and ventricular arrhythmias. Advances in the field were slowed by regulatory, scientific, clinical, and economic barriers. This review outlines the imp...